BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schon EA, DiMauro S, Hirano M, Gilkerson RW. Therapeutic prospects for mitochondrial disease. Trends Mol Med 2010;16:268-76. [PMID: 20556877 DOI: 10.1016/j.molmed.2010.04.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Protective role of melatonin in mitochondrial dysfunction and related disorders. Arch Toxicol 2015;89:923-39. [DOI: 10.1007/s00204-015-1475-z] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
2 Schoultz I, Söderholm JD, Mckay DM. Is metabolic stress a common denominator in inflammatory bowel disease?: . Inflammatory Bowel Diseases 2011;17:2008-18. [DOI: 10.1002/ibd.21556] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
3 Grace HE, Galdun P 3rd, Lesnefsky EJ, West FD, Iyer S. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders. Stem Cells Dev 2019;28:846-59. [PMID: 31017045 DOI: 10.1089/scd.2019.0045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
4 Burstein MT, Titorenko VI. A mitochondrially targeted compound delays aging in yeast through a mechanism linking mitochondrial membrane lipid metabolism to mitochondrial redox biology. Redox Biol 2014;2:305-7. [PMID: 24563847 DOI: 10.1016/j.redox.2014.01.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
5 Baburina Y, Lomovsky A, Krestinina O. Melatonin as a Potential Multitherapeutic Agent. J Pers Med 2021;11:274. [PMID: 33917344 DOI: 10.3390/jpm11040274] [Reference Citation Analysis]
6 Kamalden TA, Ji D, Osborne NN. Rotenone-Induced Death of RGC-5 Cells is Caspase Independent, Involves the JNK and p38 Pathways and is Attenuated by Specific Green Tea Flavonoids. Neurochem Res 2012;37:1091-101. [DOI: 10.1007/s11064-012-0713-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
7 Bruni F, Lightowlers RN, Chrzanowska-Lightowlers ZM. Human mitochondrial nucleases. FEBS J 2017;284:1767-77. [PMID: 27926991 DOI: 10.1111/febs.13981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
8 Beach A, Richard VR, Leonov A, Burstein MT, Bourque SD, Koupaki O, Juneau M, Feldman R, Iouk T, Titorenko VI. Mitochondrial membrane lipidome defines yeast longevity. Aging (Albany NY) 2013;5:551-74. [PMID: 23924582 DOI: 10.18632/aging.100578] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
9 Fišar Z. Drugs related to monoamine oxidase activity. Prog Neuropsychopharmacol Biol Psychiatry 2016;69:112-24. [PMID: 26944656 DOI: 10.1016/j.pnpbp.2016.02.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
10 Cardinali DP, Pagano ES, Scacchi Bernasconi PA, Reynoso R, Scacchi P. Melatonin and mitochondrial dysfunction in the central nervous system. Hormones and Behavior 2013;63:322-30. [DOI: 10.1016/j.yhbeh.2012.02.020] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 7.2] [Reference Citation Analysis]
11 Srinivasan V, Spence DW, Pandi-Perumal SR, Brown GM, Cardinali DP. Melatonin in mitochondrial dysfunction and related disorders. Int J Alzheimers Dis 2011;2011:326320. [PMID: 21629741 DOI: 10.4061/2011/326320] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wojewoda M, Duszyński J, Więckowski M, Szczepanowska J. Effect of selenite on basic mitochondrial function in human osteosarcoma cells with chronic mitochondrial stress. Mitochondrion 2012;12:149-55. [PMID: 21742063 DOI: 10.1016/j.mito.2011.06.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
13 Yang Q, Liu P, Anderson NS, Shpilka T, Du Y, Naresh NU, Li R, Zhu LJ, Luk K, Lavelle J, Zeinert RD, Chien P, Wolfe SA, Haynes CM. LONP-1 and ATFS-1 sustain deleterious heteroplasmy by promoting mtDNA replication in dysfunctional mitochondria. Nat Cell Biol. [DOI: 10.1038/s41556-021-00840-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Yu H, Koilkonda RD, Chou TH, Porciatti V, Mehta A, Hentall ID, Chiodo VA, Boye SL, Hauswirth WW, Lewin AS, Guy J. Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in mice. Proc Natl Acad Sci U S A 2015;112:E5689-98. [PMID: 26438859 DOI: 10.1073/pnas.1506129112] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
15 Papadopoulou LC, Tsiftsoglou AS. Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders. Pharm Res 2011;28:2639-56. [PMID: 21874377 DOI: 10.1007/s11095-011-0546-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
16 Rodríguez-Aguilera JC, Cortés AB, Fernández-Ayala DJ, Navas P. Biochemical Assessment of Coenzyme Q10 Deficiency. J Clin Med 2017;6:E27. [PMID: 28273876 DOI: 10.3390/jcm6030027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
17 Quarato G, Piccoli C, Scrima R, Capitanio N. Functional imaging of membrane potential at the single mitochondrion level: Possible application for diagnosis of human diseases. Mitochondrion 2011;11:764-73. [DOI: 10.1016/j.mito.2011.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
18 Davis RE, Williams M. Mitochondrial function and dysfunction: an update. J Pharmacol Exp Ther 2012;342:598-607. [PMID: 22700430 DOI: 10.1124/jpet.112.192104] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
19 Peralta S, Torraco A, Iommarini L, Diaz F. Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies. Mitochondrion 2015;23:71-80. [PMID: 25638392 DOI: 10.1016/j.mito.2015.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
20 Milone M, Wong L. Diagnosis of mitochondrial myopathies. Molecular Genetics and Metabolism 2013;110:35-41. [DOI: 10.1016/j.ymgme.2013.07.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
21 Hirano M, Emmanuele V, Quinzii CM. Emerging therapies for mitochondrial diseases. Essays Biochem 2018;62:467-81. [PMID: 29980632 DOI: 10.1042/EBC20170114] [Cited by in Crossref: 59] [Cited by in F6Publishing: 25] [Article Influence: 14.8] [Reference Citation Analysis]
22 Moraes CT, Bacman SR, Williams SL. Manipulating mitochondrial genomes in the clinic: playing by different rules. Trends Cell Biol 2014;24:209-11. [PMID: 24679453 DOI: 10.1016/j.tcb.2014.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Saada A. The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases. Mol Genet Metab 2011;104:39-47. [PMID: 21835663 DOI: 10.1016/j.ymgme.2011.07.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
24 Martín-Jiménez R, Martín-Hernández E, Cabello A, García-Silva MT, Arenas J, Campos Y. Clinical and cellular consequences of the mutation m.12300G>A in the mitochondrial tRNA(Leu(CUN)) gene. Mitochondrion 2012;12:288-93. [PMID: 22094595 DOI: 10.1016/j.mito.2011.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Hicks KA, Howe DK, Leung A, Denver DR, Estes S. In vivo quantification reveals extensive natural variation in mitochondrial form and function in Caenorhabditis briggsae. PLoS One 2012;7:e43837. [PMID: 22952781 DOI: 10.1371/journal.pone.0043837] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
26 Branco AF, Ferreira A, Simões RF, Magalhães-novais S, Zehowski C, Cope E, Silva AM, Pereira D, Sardão VA, Cunha-oliveira T. Ketogenic diets: from cancer to mitochondrial diseases and beyond. Eur J Clin Invest 2016;46:285-98. [DOI: 10.1111/eci.12591] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 11.7] [Reference Citation Analysis]
27 Garipler G, Mutlu N, Lack NA, Dunn CD. Deletion of conserved protein phosphatases reverses defects associated with mitochondrial DNA damage in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 2014;111:1473-8. [PMID: 24474773 DOI: 10.1073/pnas.1312399111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
28 Fernández-Ayala DJ, Jiménez-Gancedo S, Guerra I, Navas P. Invertebrate models for coenzyme q10 deficiency. Mol Syndromol 2014;5:170-9. [PMID: 25126050 DOI: 10.1159/000362751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Kashani IR, Rajabi Z, Akbari M, Hassanzadeh G, Mohseni A, Eramsadati MK, Rafiee K, Beyer C, Kipp M, Zendedel A. Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis. Exp Brain Res 2014;232:2835-46. [PMID: 24798398 DOI: 10.1007/s00221-014-3946-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
30 Heller A, Brockhoff G, Goepferich A. Targeting drugs to mitochondria. European Journal of Pharmaceutics and Biopharmaceutics 2012;82:1-18. [DOI: 10.1016/j.ejpb.2012.05.014] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 9.2] [Reference Citation Analysis]
31 Aiyar RS, Bohnert M, Duvezin-Caubet S, Voisset C, Gagneur J, Fritsch ES, Couplan E, von der Malsburg K, Funaya C, Soubigou F, Courtin F, Suresh S, Kucharczyk R, Evrard J, Antony C, St Onge RP, Blondel M, di Rago JP, van der Laan M, Steinmetz LM. Mitochondrial protein sorting as a therapeutic target for ATP synthase disorders. Nat Commun 2014;5:5585. [PMID: 25519239 DOI: 10.1038/ncomms6585] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
32 Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, Ferrick DA, Murphy AN. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One 2011;6:e21746. [PMID: 21799747 DOI: 10.1371/journal.pone.0021746] [Cited by in Crossref: 294] [Cited by in F6Publishing: 280] [Article Influence: 26.7] [Reference Citation Analysis]
33 Figueira TR, Barros MH, Camargo AA, Castilho RF, Ferreira JC, Kowaltowski AJ, Sluse FE, Souza-Pinto NC, Vercesi AE. Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid Redox Signal 2013;18:2029-74. [PMID: 23244576 DOI: 10.1089/ars.2012.4729] [Cited by in Crossref: 255] [Cited by in F6Publishing: 238] [Article Influence: 28.3] [Reference Citation Analysis]
34 Fišar Z, Musílek K, Benek O, Hroch L, Vinklářová L, Schmidt M, Hroudová J, Raboch J. Effects of novel 17β-hydroxysteroid dehydrogenase type 10 inhibitors on mitochondrial respiration. Toxicol Lett 2021;339:12-9. [PMID: 33359020 DOI: 10.1016/j.toxlet.2020.12.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Biasutto L, Szabo' I, Zoratti M. Mitochondrial effects of plant-made compounds. Antioxid Redox Signal 2011;15:3039-59. [PMID: 21554022 DOI: 10.1089/ars.2011.4021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
36 Schatten H, Sun QY, Prather R. The impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility. Reprod Biol Endocrinol 2014;12:111. [PMID: 25421171 DOI: 10.1186/1477-7827-12-111] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
37 McInnes J. Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr Metab (Lond) 2013;10:63. [PMID: 24499129 DOI: 10.1186/1743-7075-10-63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
38 Vajrala VS, Suraniti E, Garrigue P, Goudeau B, Rigoulet M, Devin A, Sojic N, Arbault S. Optical microwell array for large scale studies of single mitochondria metabolic responses. Anal Bioanal Chem 2014;406:931-41. [PMID: 23892878 DOI: 10.1007/s00216-013-7211-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
39 Komen JC, Thorburn DR. Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models. Br J Pharmacol 2014;171:1818-36. [PMID: 24102298 DOI: 10.1111/bph.12413] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]
40 Bradshaw E, Yoshida M, Ling F. Mitochondrial fission proteins Fis1 and Mdv1, but not Dnm1, play a role in maintenance of heteroplasmy in budding yeast. FEBS Lett 2012;586:1245-51. [PMID: 22575664 DOI: 10.1016/j.febslet.2012.03.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
41 Chen WW, Birsoy K, Mihaylova MM, Snitkin H, Stasinski I, Yucel B, Bayraktar EC, Carette JE, Clish CB, Brummelkamp TR, Sabatini DD, Sabatini DM. Inhibition of ATPIF1 ameliorates severe mitochondrial respiratory chain dysfunction in mammalian cells. Cell Rep 2014;7:27-34. [PMID: 24685140 DOI: 10.1016/j.celrep.2014.02.046] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
42 Gianazza E, Eberini I, Sensi C, Barile M, Vergani L, Vanoni MA. Energy matters: mitochondrial proteomics for biomedicine. Proteomics 2011;11:657-74. [PMID: 21241019 DOI: 10.1002/pmic.201000412] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
43 Ballard JW, Melvin RG. Early life benefits and later life costs of a two amino acid deletion in Drosophila simulans. Evolution 2011;65:1400-12. [PMID: 21143473 DOI: 10.1111/j.1558-5646.2010.01209.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
44 Yu-Wai-Man P. Genetic manipulation for inherited neurodegenerative diseases: myth or reality? Br J Ophthalmol 2016;100:1322-31. [PMID: 27002113 DOI: 10.1136/bjophthalmol-2015-308329] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
45 Jarrett SG, Boulton ME. Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med. 2012;33:399-417. [PMID: 22510306 DOI: 10.1016/j.mam.2012.03.009] [Cited by in Crossref: 274] [Cited by in F6Publishing: 257] [Article Influence: 27.4] [Reference Citation Analysis]
46 Clark J, Dai Y, Simon DK. Do somatic mitochondrial DNA mutations contribute to Parkinson's disease? Parkinsons Dis 2011;2011:659694. [PMID: 21603185 DOI: 10.4061/2011/659694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
47 Morán M, Moreno-Lastres D, Marín-Buera L, Arenas J, Martín MA, Ugalde C. Mitochondrial respiratory chain dysfunction: implications in neurodegeneration. Free Radic Biol Med. 2012;53:595-609. [PMID: 22595027 DOI: 10.1016/j.freeradbiomed.2012.05.009] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 10.0] [Reference Citation Analysis]
48 Kasote DM, Hegde MV, Katyare SS. Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy. Biofactors 2013;39:392-406. [PMID: 23460132 DOI: 10.1002/biof.1093] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
49 Maj M, Sriskandarajah N, Hung V, Browne I, Shah B, Weadge A, Jamieson NL, Tropak M, Cameron JM, Addis JB, Robinson BH. Identification of drug candidates which increase cytochrome c oxidase activity in deficient patient fibroblasts. Mitochondrion 2011;11:264-72. [PMID: 21050896 DOI: 10.1016/j.mito.2010.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
50 Lu J, Huang Y. Childhood mitochondrial encephalomyopathies: clinical course, diagnosis, neuroimaging findings, mtDNA mutations and outcome in six children. Ital J Pediatr 2013;39:60. [PMID: 24069936 DOI: 10.1186/1824-7288-39-60] [Reference Citation Analysis]
51 Tam ZY, Gruber J, Halliwell B, Gunawan R. Context-Dependent Role of Mitochondrial Fusion-Fission in Clonal Expansion of mtDNA Mutations. PLoS Comput Biol 2015;11:e1004183. [PMID: 25996936 DOI: 10.1371/journal.pcbi.1004183] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
52 Bouaita A, Augustin S, Lechauve C, Cwerman-Thibault H, Bénit P, Simonutti M, Paques M, Rustin P, Sahel JA, Corral-Debrinski M. Downregulation of apoptosis-inducing factor in Harlequin mice induces progressive and severe optic atrophy which is durably prevented by AAV2-AIF1 gene therapy. Brain 2012;135:35-52. [PMID: 22120150 DOI: 10.1093/brain/awr290] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
53 Miles MV, Miles L, Horn PS, Degrauw TJ. Enzyme inducing antiepileptic drugs are associated with mitochondrial proliferation and increased cytochrome c oxidase activity in muscle of children with epilepsy. Epilepsy Research 2012;98:76-87. [DOI: 10.1016/j.eplepsyres.2011.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Levin L, Mishmar D. A Genetic View of the Mitochondrial Role in Ageing: Killing Us Softly. In: Atzmon, Phd G, editor. Longevity Genes. New York: Springer; 2015. pp. 89-106. [DOI: 10.1007/978-1-4939-2404-2_4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
55 Tang F, Wang B, Li N, Wu Y, Jia J, Suo T, Chen Q, Liu YJ, Tang J. RNF185, a novel mitochondrial ubiquitin E3 ligase, regulates autophagy through interaction with BNIP1. PLoS One 2011;6:e24367. [PMID: 21931693 DOI: 10.1371/journal.pone.0024367] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
56 Liu Y, Nguyen P, Baris TZ, Poirier MC. Molecular Analysis of Mitochondrial Compromise in Rodent Cardiomyocytes Exposed Long Term to Nucleoside Reverse Transcriptase Inhibitors (NRTIs). Cardiovasc Toxicol 2012;12:123-34. [DOI: 10.1007/s12012-011-9148-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
57 Liu Y, Shim E, Crespo-mejias Y, Nguyen P, Gibbons A, Liu D, Shide E, Poirier MC. Cardiomyocytes are Protected from Antiretroviral Nucleoside Analog-Induced Mitochondrial Toxicity by Overexpression of PGC-1α. Cardiovasc Toxicol 2015;15:224-31. [DOI: 10.1007/s12012-014-9288-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Qiu C, Kumar S, Guo J, Lu J, Shi S, Kalachikov SM, Russo JJ, Naini AB, Schon EA, Ju J. Mitochondrial single nucleotide polymorphism genotyping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using cleavable biotinylated dideoxynucleotides. Anal Biochem 2012;427:202-10. [PMID: 22579594 DOI: 10.1016/j.ab.2012.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
59 Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res 2011;30:81-114. [PMID: 21112411 DOI: 10.1016/j.preteyeres.2010.11.002] [Cited by in Crossref: 325] [Cited by in F6Publishing: 293] [Article Influence: 27.1] [Reference Citation Analysis]
60 Peixoto PM, Dejean LM, Kinnally KW. The therapeutic potential of mitochondrial channels in cancer, ischemia-reperfusion injury, and neurodegeneration. Mitochondrion 2012;12:14-23. [PMID: 21406252 DOI: 10.1016/j.mito.2011.03.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
61 Gella A, Prada-Dacasa P, Carrascal M, Urpi A, González-Torres M, Abian J, Sanz E, Quintana A. Mitochondrial Proteome of Affected Glutamatergic Neurons in a Mouse Model of Leigh Syndrome. Front Cell Dev Biol 2020;8:660. [PMID: 32850799 DOI: 10.3389/fcell.2020.00660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
62 Heaton R, Millichap L, Saleem F, Gannon J, Begum G, Hargreaves IP. Current biochemical treatments of mitochondrial respiratory chain disorders. Expert Opinion on Orphan Drugs 2019;7:277-85. [DOI: 10.1080/21678707.2019.1638250] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Jodeiri Farshbaf M, Ghaedi K, Megraw TL, Curtiss J, Shirani Faradonbeh M, Vaziri P, Nasr-Esfahani MH. Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders? Neuromolecular Med 2016;18:1-15. [PMID: 26611102 DOI: 10.1007/s12017-015-8370-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
64 Lasserre JP, Dautant A, Aiyar RS, Kucharczyk R, Glatigny A, Tribouillard-Tanvier D, Rytka J, Blondel M, Skoczen N, Reynier P, Pitayu L, Rötig A, Delahodde A, Steinmetz LM, Dujardin G, Procaccio V, di Rago JP. Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies. Dis Model Mech 2015;8:509-26. [PMID: 26035862 DOI: 10.1242/dmm.020438] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 13.8] [Reference Citation Analysis]
65 Menezes MJ, Riley LG, Christodoulou J. Mitochondrial respiratory chain disorders in childhood: Insights into diagnosis and management in the new era of genomic medicine. Biochimica et Biophysica Acta (BBA) - General Subjects 2014;1840:1368-79. [DOI: 10.1016/j.bbagen.2013.12.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
66 Suraniti E, Vajrala VS, Goudeau B, Bottari SP, Rigoulet M, Devin A, Sojic N, Arbault S. Monitoring metabolic responses of single mitochondria within poly(dimethylsiloxane) wells: study of their endogenous reduced nicotinamide adenine dinucleotide evolution. Anal Chem 2013;85:5146-52. [PMID: 23600852 DOI: 10.1021/ac400494e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]